These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6334548)

  • 1. Studies with a human plasma-derived immunosuppressive, anti-lymphoma factor.
    Farmer JL; Prager MD
    Cancer Immunol Immunother; 1984; 18(2):101-6. PubMed ID: 6334548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related protein is a possible autocrine growth inhibitor for lymphocytes.
    Adachi N; Yamaguchi K; Miyake Y; Honda S; Nagasaki K; Akiyama Y; Adachi I; Abe K
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1088-94. PubMed ID: 2306230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
    Miura T; Maekawa T; Kurashige S; Mitsuhashi S
    Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial mechanistic studies with merbarone (NSC 336628).
    Cooney DA; Covey JM; Kang GJ; Dalal M; McMahon JB; Johns DG
    Biochem Pharmacol; 1985 Sep; 34(18):3395-8. PubMed ID: 3840022
    [No Abstract]   [Full Text] [Related]  

  • 6. The dose dependent effect of cyclic AMP on ribonucleotide reductase in mitogen stimulated mononuclear cells.
    Albert D; Kowalski J; Nodzenski E; Micek M; Wu P
    Biochem Biophys Res Commun; 1990 Mar; 167(2):383-90. PubMed ID: 2157402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
    Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes.
    Helderman JH; Strom TB
    J Biol Chem; 1979 Aug; 254(15):7203-7. PubMed ID: 313395
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel mechanisms of brequinar sodium immunosuppression on T cell activation.
    Forrest TL; Ware RE; Howard T; Jaffee BD; Denning SM
    Transplantation; 1994 Oct; 58(8):920-6. PubMed ID: 7940736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM; Bauman GP; Brooks WH; Roszman TL
    Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte inhibitory factors (chalones) extracted from lymphoid organs. Extraction, partial purification and immunosuppressive properties.
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Transplant Proc; 1972 Dec; 4(4):531-6. PubMed ID: 4264869
    [No Abstract]   [Full Text] [Related]  

  • 12. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L; Lipsky PE
    J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
    Kataoka T; Oh-hashi F
    Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor.
    Maier T; Levy JG
    Cancer Immunol Immunother; 1982; 13(2):134-9. PubMed ID: 6819080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
    Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
    Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-nonspecific action of soluble immunosuppressive factor produced by murine immature erythroid cells.
    Mitasov AV; Tsyrlova IG; Kiselev SV; Kozlov VV
    Ann N Y Acad Sci; 1991; 628():399-409. PubMed ID: 2069316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte chalone concentrates and their effects upon leukemic cells in vitro.
    Attallah AM; Houck JC
    Boll Ist Sieroter Milan; 1975 Jul; 54(3):227-34. PubMed ID: 130145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
    Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
    J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha.
    Baxevanis CN; Gritzapis AD; Spanakos G; Tsitsilonis OE; Papamichail M
    Cancer Immunol Immunother; 1995 Jun; 40(6):410-8. PubMed ID: 7543022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary characterization in mice of the effect of isoprinosine on the immune system.
    Vecchi A; Sironi M; Spreafico F
    Cancer Treat Rep; 1978 Nov; 62(11):1975-9. PubMed ID: 83191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.